TickerFacts.

PetMed Express Inc (PETS): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$49.29M
Year ended 2026-03-31
-$21.52M
Trailing 12 months to 2026-06-30
$27.03M2022-03-31: $27.03M2023-03-31: $9.60M2024-03-31: -$1.11M2025-03-31: $5.51M2026-03-31: -$49.29M-$49.29M
2022-03-31 EBITDA (USD) 2026-03-31
Period endedEBITDAChange YoYSource filing
2026-03-31-$49.29Mn/m2026-06-02, From 2025-04-01
2025-03-31$5.51Mn/m2026-06-02, From 2024-04-01
2024-03-31-$1.11Mn/m2026-06-02, From 2023-04-01
2023-03-31$9.60M-64.5%2025-10-14, From 2022-04-01
2022-03-31$27.03Mn/a2024-06-14, From 2021-04-01

EBITDA at similar companies

Companies with the same SEC industry code (Retail-Drug Stores and Proprietary Stores), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
PetMed Express Inc (PETS)2026-03-31-$49.29Mn/m
Ridgetech Inc. (RDGT)2026-03-31-$1.50Mn/m
Guardian Pharmacy Services, Inc. (GRDN)2025-12-31$95.04Mn/m
CVS Health Corp (CVS)2025-12-31$9.27B-29.3%

Compare PETS, RDGT, GRDN, CVS side by side · Screen every company in Retail-Drug Stores and Proprietary Stores ↗